Prescription Drug Price Reporting Act

House Bill 5239 - Prescription Drug Price Reporting Act: Overview, Status, and Impact

Hozzl · 2022-10-28T01:46:10Z

Explore the details of House Bill 5239 Prescription Drug Price Reporting Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

10/28/2022, 1:46 AM

Current Status of Bill HR 5239

Bill HR 5239 is currently in the status of Bill Introduced since November 21, 2019. Bill HR 5239 was introduced during Congress 116 and was introduced to the House on November 21, 2019. Bill HR 5239's most recent activity was Referred to the Subcommittee on Health. as of November 22, 2019

Bipartisan Support of Bill HR 5239

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 5239

Primary Policy Focus

Health

Comments

Sponsors and Cosponsors of HR 5239

David P. Joyce

OhioRepublican

Latest Bills

Canterbury Shaker Village National Heritage Area Study Authorization Act

Bill S 2801July 27, 2026

Strengthening America’s Turning Point Act

Bill S 1518July 26, 2026

Unlocking Native Lands and Opportunities for Commerce and Key Economic Developments Act of 2025

Bill S 3383July 25, 2026

To amend the Research and Development, Competition, and Innovation Act to support nucleic acid screening, and for other purposes.

Bill HR 3029July 25, 2026